S-1/A: Core Scientific Files Amendment for Resale of 10.8 Million Shares Post-Bankruptcy

Core Scientific files an amendment to its S-1 registration statement for the resale of approximately 10.8 million shares of common stock by selling stockholders following its emergence from Chapter 11 bankruptcy.

Summary

• Core Scientific has filed an amendment to its Form S-1 registration statement related to the resale of common stock by certain selling stockholders.
• The filing involves the resale of up to 10,735,143 shares by Tospring Technology Limited (Bitmain) and up to 60,608 shares by certain holders of Old Convertible Notes.
• These shares were issued pursuant to an asset purchase agreement with Bitmain and a bankruptcy court order.
• Core Scientific will not receive any proceeds from the sale of these shares.
• The company emerged from Chapter 11 bankruptcy on January 23, 2024, after satisfying the conditions of its reorganization plan.
• As part of the reorganization, Core Scientific issued new common stock, warrants, contingent value rights, secured convertible notes, and secured notes.
• The company's common stock, Tranche 1 warrants, and Tranche 2 warrants are listed on the Nasdaq Global Select Market under the symbols CORZ, CORZW, and CORZZ, respectively.
• On April 26, 2024, the last reported sales prices of Core's Common Stock, Tranche 1 Warrants and Tranche 2 Warrants were $3.48, $1.14 and $1.88, respectively.

Sentiment

Score: 6

Explanation: The document is neutral, primarily focused on factual information regarding the share resale and the company's financial restructuring. While the bankruptcy is a negative event, the emergence and reorganization are positive steps.

Positives

• The company has emerged from Chapter 11 bankruptcy, indicating a restructuring of its finances.
• Core Scientific's securities are listed on Nasdaq, providing liquidity for investors.

Negatives

• The company recently underwent Chapter 11 bankruptcy, indicating past financial distress.
• The resale of shares by existing stockholders could put downward pressure on the stock price.

Risks

• Investing in the company's securities involves a high degree of risk, as detailed in the Risk Factors section of the prospectus.
• The company's success depends on its ability to earn bitcoin profitably and attract hosting customers.
• The company is subject to risks associated with significant electric power needs and the limited availability of power resources.
• The company may be vulnerable to physical security breaches and cybersecurity threats.
• Digital assets, and bitcoin in particular, are subject to price volatility.

Future Outlook

The company anticipates that subsequent events and developments will cause the Companys assessments to change and may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.

Industry Context

The announcement reflects the ongoing dynamics within the digital asset mining industry, including financial restructuring, capital raising, and adjustments to business strategies in response to market conditions and regulatory developments.

Comparison to Industry Standards

• Core Scientific's restructuring and subsequent actions can be compared to other companies in the cryptocurrency mining space that have faced similar challenges due to market volatility and regulatory uncertainty.
• Companies like Marathon Digital Holdings, Riot Platforms, and Hut 8 have also navigated fluctuating bitcoin prices and operational adjustments.
• The ability to secure power capacity and optimize mining operations is a key differentiator, similar to strategies employed by Bitfarms and CleanSpark.
• The focus on energy efficiency and sustainable power sources aligns with industry trends and increasing ESG considerations, as seen with companies like Iris Energy.
• The reliance on Bitmain for mining equipment is common in the industry, but diversification of suppliers could mitigate risks, as demonstrated by companies exploring alternative manufacturers.

Management Changes

Stakeholder Impact

• Shareholders may experience dilution due to the resale of shares by existing stockholders.
• The company's ability to execute its business plan and generate future value will impact all stakeholders, including employees, customers, and creditors.

Next Steps

• The Selling Stockholders will determine when and how they will dispose of the securities registered for resale under this prospectus.
• The company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.

Key Dates

Keywords

Core Scientific, common stock, resale, Bitmain, bankruptcy, Chapter 11, securities, warrants, offering, stockholders, CORZ, CORZW, CORZZ